These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18647326)

  • 21. Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas.
    Christiaans I; Kenter SB; Brink HC; van Os TA; Baas F; van den Munckhof P; Kidd AM; Hulsebos TJ
    J Med Genet; 2011 Feb; 48(2):93-7. PubMed ID: 20930055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
    Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
    Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors.
    Eaton KW; Tooke LS; Wainwright LM; Judkins AR; Biegel JA
    Pediatr Blood Cancer; 2011 Jan; 56(1):7-15. PubMed ID: 21108436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Report of a patient with a constitutional missense mutation in SMARCB1, Coffin-Siris phenotype, and schwannomatosis.
    Gossai N; Biegel JA; Messiaen L; Berry SA; Moertel CL
    Am J Med Genet A; 2015 Dec; 167A(12):3186-91. PubMed ID: 26364901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation.
    Bacci C; Sestini R; Provenzano A; Paganini I; Mancini I; Porfirio B; Vivarelli R; Genuardi M; Papi L
    Neurogenetics; 2010 Feb; 11(1):73-80. PubMed ID: 19582488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial schwannomatosis with a germline mutation of SMARCB1 in Japan.
    Asai K; Tani S; Mineharu Y; Tsurusaki Y; Imai Y; Agawa Y; Iwaki K; Matsumoto N; Sakai N
    Brain Tumor Pathol; 2015 Jul; 32(3):216-20. PubMed ID: 25631985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broadening the spectrum of SMARCB1-associated malignant tumors: a case of uterine leiomyosarcoma in a patient with schwannomatosis.
    Paganini I; Sestini R; Cacciatore M; Capone GL; Candita L; Paolello C; Sbaraglia M; Dei Tos AP; Rossi S; Papi L
    Hum Pathol; 2015 Aug; 46(8):1226-31. PubMed ID: 26001331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA-based analysis of two SMARCB1 mutations associated with familial schwannomatosis with meningiomas.
    Melean G; Velasco A; Hernández-Imaz E; Rodríguez-Álvarez FJ; Martín Y; Valero A; Hernández-Chico C
    Neurogenetics; 2012 Aug; 13(3):267-74. PubMed ID: 22752724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 1 papillary renal cell carcinoma in a patient with schwannomatosis: Mosaic versus loss of SMARCB1 expression in respectively schwannoma and renal tumor cells.
    Hulsebos TJ; Kenter S; Baas F; Nannenberg EA; Bleeker FE; van Minkelen R; van den Ouweland AM; Wesseling P; Flucke U
    Genes Chromosomes Cancer; 2016 Apr; 55(4):350-4. PubMed ID: 26799435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
    Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
    Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A germline missense mutation in COQ6 is associated with susceptibility to familial schwannomatosis.
    Zhang K; Lin JW; Wang J; Wu X; Gao H; Hsieh YC; Hwu P; Liu YR; Su L; Chiou HY; Wang D; Yuan YC; Whang-Peng J; Chiu WT; Yen Y
    Genet Med; 2014 Oct; 16(10):787-92. PubMed ID: 24763291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1.
    Swensen JJ; Keyser J; Coffin CM; Biegel JA; Viskochil DH; Williams MS
    J Med Genet; 2009 Jan; 46(1):68-72. PubMed ID: 19124645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
    Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
    Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Rare Case of Familial Schwannomatosis Showing Intrafamilial Variability with Identification of a Shared Novel Germline
    Lee JH; Jeong JS; Chae KJ; Han YH; Kim SR; Lee YC
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.
    Plotkin SR; Blakeley JO; Evans DG; Hanemann CO; Hulsebos TJ; Hunter-Schaedle K; Kalpana GV; Korf B; Messiaen L; Papi L; Ratner N; Sherman LS; Smith MJ; Stemmer-Rachamimov AO; Vitte J; Giovannini M
    Am J Med Genet A; 2013 Mar; 161A(3):405-16. PubMed ID: 23401320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An unusual case of schwannomatosis with bilateral maxillary sinus schwannomas and a novel SMARCB1 gene mutation.
    Toms J; Harrison J; Richard H; Childers A; Reiter ER; Graham RS
    J Neurosurg Spine; 2016 Jan; 24(1):160-6. PubMed ID: 26431068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor.
    Yamamoto H; Kohashi K; Tsuneyoshi M; Oda Y
    Pathobiology; 2011; 78(3):132-9. PubMed ID: 21613800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SMARCB1 mutations are not a common cause of multiple meningiomas.
    Hadfield KD; Smith MJ; Trump D; Newman WG; Evans DG
    J Med Genet; 2010 Aug; 47(8):567-8. PubMed ID: 20472658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.
    Kehrer-Sawatzki H; Farschtschi S; Mautner VF; Cooper DN
    Hum Genet; 2017 Feb; 136(2):129-148. PubMed ID: 27921248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
    Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.